158 results on '"Levy, Michael"'
Search Results
2. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis
3. EUS-Guided Transluminal Interventions
4. Mo1131 METHYLATED DNA MARKERS TO DIFFERENTIATE MALIGNANT FROM BENIGN BILIARY STRICTURES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
5. Picking a Zebra Among Horses: More Difficult Than You Think!
6. 1121: UTILIZATION OF ARTIFICIAL INTELLIGENCE AND OCCLUSION BLOCK HEATMAP TECHNIQUE TO EXTRACT AND RANK CHOLANGIOSCOPIC FEATURES ASSOCIATED WITH MALIGNANT BILIARY STRICTURES
7. Comparison of Methods to Detect Neoplasia in Patients Undergoing Endoscopic Ultrasound-Guided Fine-Needle Aspiration
8. Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis
9. Sa304 METHYLATED DNA MARKERS IN TISSUE FROM SURGICALLY RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS DETECT HIGH-GRADE DYSPLASIA WITH OR WITHOUT INVASIVE CANCER IN THE FIELD
10. Su305 ENDOSCOPIC ULTRASOUND FOR PANCREAS INTRATUMORAL MICROBIOME SIGNATURE PROFILING: COMPOSITION, DIVERSITY, AND POTENTIAL UTILITY
11. Sa332 A CLINICAL PREDICTION MODEL TO DIFFERENTIATE MALIGNANT FROM BENIGN BILIARY STRICTURE
12. Tu1420 INCIDENCE AND EFFECT DURATION OF IMMUNE CHECKPOINT INHIBITOR RELATED PANCREAS ADVERSE EVENTS
13. Sa1419 ACUTE PANCREATITIS IN PATIENTS WITH AND WITHOUT HISTORY OF BARIATRIC SURGERY: A CASE MATCHED STUDY
14. 1269 PANCREATIC CANCER DETECTION USING METHYLATED DNA MARKERS IN PANCREATIC JUICE: A PROSPECTIVE MULTICENTER VALIDATION STUDY
15. 1149 PRIMARY PANCREAS NEUROENDOCRINE TUMOR SIZE AND PROLIFERATION INDEX ARE CLINICALLY HELPFUL BUT ARE THEY ENOUGH? A SINGLE CENTER 20-YEAR EXPERIENCE.
16. Tu1604 DEVELOPMENT OF AN EUS CONVOLUTIONAL NEURAL NETWORK ALGORITHM FOR THE DIFFERENTIATION OF PANCREATIC DUCTAL ADENOCARCINOMA FROM BENIGN CONDITIONS OF THE PANCREAS
17. 207 QUANTIFICATION OF PANCREATIC FAT ON ABDOMINAL COMPUTED TOMOGRAPHY SCANS USING A DEEP-CONVOLUTIONAL NEURAL NETWORK TRAINED FOR PANCREAS SEGMENTATION
18. Mo1369 IDENTIFICATION OF LIPOCALIN-2 EXPRESSION BY DIGITAL MRNA IN THE PDAC TUMOR MICROENVIRONMENT VIA EUS FINE NEEDLE BIOPSY IS FEASIBLE AND HAS THE POTENTIAL TO BE A THERAPEUTIC TARGET
19. Su1497 PREDICTORS OF ADVANCED NEOPLSIA AND LONG TERM OUTCOMES IN SURGICALLY RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
20. Mo1347 ROLE OF COMPUTED TOMOGRAPHY IN THE EARLY DETECTION OF PANCREATIC CANCER: BENEFIT BEYOND LEAD TIME
21. Mo1348 AN EARLY INSIGHT INTO GENOMIC STRUCTURAL VARIATION IN TREATMENT NAIVE PANCREATIC DUCTAL ADENOCARCINOMA
22. Mo1356 AN INSIGHT INTO FIBROGENIC STIMULANTS IN THE PDAC EUS FINE NEEDLE BIOPSY TUMOR MICROENVIRONMENT REVEALED THAT A MEMBER OF THE CEA FAMLY MAY HAVE THE POTENTIAL TO BE AN ANTIBODY DRUG TARGET
23. Impact of lymph node staging on therapy of esophageal carcinoma
24. Sa1375 – The Utility of Ca 19-9 in Patients Undergoing Eus for Pancreatic Ductal Adenocarcinoma: Single Center Experience Over 2 Decades
25. Mo1365 – Sensitivity of Computerized Tomography During Prediagnostic Course of Pancreatic Ductal Adenocarcinoma
26. Sa1348 – Eus Detection of Trace Ascites in Pancreatic Ductal Adenocarcinoma is Associated with Poor Resectability Status and Shortened Survival: An Evaluation Over 21 Years
27. Sa1691 – Prospective Evaluation of the Clinical Impact of Hematogenous Tumor Seeding (Tumoremia) Following Eus Fna of Primary Pancreatic Ductal Adenocarcinoma
28. Su1050 – Comparison of Fish Versus Ddpcr-Based Gene Copy Assessment for Ancillary Eus Fna Cytologic Testing As a Stand Alone Or Reflex Diagnostic Test Among a Pre-Selected Diagnostically Challanging Pdac Cohort
29. Su1445 – Is Chronic Pancreatitis with High Bmi Different from Those with Normal Or Low Bmi?
30. 795 - Impact of Single Fluid-Filled Intragastric Balloon on Metabolic Parameters and Nonalcoholic Steatohepatitis: A Prospective Paired Endoscopic Ultrasound Guided Core Liver Biopsy at the Time of Balloon Placement and Removal
31. 183 - Prospective, Randomized, Double Blind Clinical Trial of Celiac Plexus Neurolysis and Celiac Ganglia Neurolysis for Pancreatic Ductal Adenocarcinoma: Impact of Total Ganglia Volume on Pain, Quality of Life and Survival
32. Tu1350 - Sojourn Time of Pancreatic Cancer Estimated from Temporal and Cross-Sectional Glycemic Profiles
33. Mo1262 - Performance Characteristics of a New Fluorescence In Situ Hybridization (FISH) Probe Set on EUS FNA as a Stand Alone or Reflex Approach for the Cytologic Diagnosis of Pancreatic Ductal Adenocarcinoma
34. Su1318 - Prospective Molecular Assessment of Kras Mutation Concordance Rate Between Peripheral Blood and Primary Tumor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing EUS FNA
35. 388 - Prospective, Randomized, Double Blind Clinical Trial of Celiac Plexus Neurolysis and Celiac Ganglia Neurolysis for Pancreatic Ductal Adenocarcinoma: Impact of Secondary Neurolytic Effects on Pain, Quality of Life, and Survival
36. Sa1981 - Prospective Cell Free DNA Assessment of the Risk of Tumor Seeding Following Primary Tumor EUS FNA with Concomitant Peripheral Blood, Portal Vein, and Hepatic Vein FNA Assessment
37. Indications and Clinical Outcomes for Islet Autotransplantation (IAT): In a High Volume Pancreas Center
38. Vasoactive Intestinal Peptide-Secreting Tumors: 24 Year Experience from a Tertiary Center
39. Is Obstructive Chronic Pancreatitis Due to Necrotizing Pacreatitis Different from other Obstructive Chronic Pancreatitis? A Large Recent Series of 176 Patients with this Uncommon Entity
40. Rituximab Maintenance Therapy Decreases Relapse Rate of Pancreaticobiliary IGG4-Related Disease
41. Acute Pancreatitis (AP) is the Initial Pancreatic Event in Half of the Patients with Chronic Pancreatitis (CP): Large Single Center Study of 499 Consecutive Patients of CP in the Recent 3 Years
42. Detection of Pancreatic Cancer by Assay of Novel Methylated DNA Markers in Pancreatic Juice: A Blinded Prospective Multi-Site Study
43. 156 Diagnostic Accuracy of EUS for Distinguishing Celiac Ganglia From Celiac Lymph Nodes
44. Sa1455 KRAS Mutant Subtype Assessment of Pancreatic and Ampullary Adenocarcinoma by EUS FNA Molecular Cytology Targeted Next Generation Sequencing
45. Sa1521 SMAD4 Biomarker Stratification Strategy via Endoscopic Ultrasound Fine Needle Aspiration Using Targeted Next-Generation Sequencing for Patients With Pancreatic and Ampullary Adenocarcinoma
46. Sa1458 Synchronous Primary Pancreatic Adenocarcinoma, a Poorly Understood Phenomenon, Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration
47. Sa1518 Impact of EUS FNA of Isolated Malignant Intra-Vascular Thrombi in Cancer Staging
48. Tu1479 The Potential of an Endoscopic Ultrasound Fine Needle Aspiration Biomarker Stratification Strategy Using Targeted Next-Generation Sequencing for Patients With Pancreatic and Ampullary Adenocarcinoma
49. Su1367 COX-2 and cPLA2 are Overexpressed in the Epithelium of Mucinous Pancreatic Cysts
50. Sa1355 Molecular Cytology Genotyping of Primary and Metastatic Gastrointestinal Stromal Tumors Using Targeted Next Generation Sequencing to Guide Therapeutic Decision Making
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.